Table 8. Society of American Gastrointestinal and Endoscopic Surgeons Recommendations Regarding Surgical Management of Colorectal Cancer Patients During the Response to the COVID-19 Crisis (https://www.sages.org/recommendations-surgical-management-colorectal-cancer-covid-19/).

Clinical Situation	Phase I	Phase II	Phase III
Large or suspicious polyps Hereditary syndromes Dysplasia/Carcinoma in situ in biopsy spe- cimens, Incomplete, questionable margins on polypectomy	For COVID-19 Phase I - III Hospitals surgery would be delayed until the pandemic abates and resources return
Early cancer in resected polyp	Consider deferring surgery vs. resection	Defer Surgery
Asymptomatic Cancer T1-2 N0	Resect	Resect vs. deferring surgery	Defer surgery
Asymptomatic Cancer Colon T3-4, N0 and Tx N+	Resect	Resect vs. deferring surgery	Consider chemotherapy vs. transfer
Rectal T3-4, N0 and Tx N+	Induction chemotherapy versus chemoradiation versus radiation, consider extended chemothe- rapy, also consider delaying surgery up to 12-16 weeks following completion of radiation
Symptomatic cancers defined as bleed- ing requiring transfusion, obstructing or near-obstructing, impending perforation	Resect	Resect, consider stent vs. stoma	Stoma vs. stent, consider transfer